A lethal phenotype associated with tissue plasminogen deficiency in humans

Hanan E Shamseldin1, Abdulrahman Aldeeri2, Zainab Babay3

  • 1Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Human Genetics
|July 16, 2016
PubMed

Insights

Researchers identified the first human knockout mutation in PLAT, a gene crucial for tissue plasminogen activator (t-PA) function. This discovery in a family with severe infant mortality may link PLAT mutations to hydranencephaly and diaphragmatic hernia.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • Tissue plasminogen activator (t-PA), encoded by PLAT, is essential for plasminogen activation and thrombosis prevention.
  • Previous studies focused on common PLAT variants, but no disease-causing mutations were identified.
  • Severe congenital anomalies like hydranencephaly and diaphragmatic hernia can lead to postnatal lethality.

Purpose of the Study:

  • To investigate the genetic basis of severe congenital anomalies and early postnatal death in a consanguineous family.
  • To identify novel mutations in the PLAT gene and their functional consequences.

Main Methods:

  • Whole exome and autozygome sequencing were performed on affected individuals from a consanguineous family.
  • Patient-derived cells were analyzed to assess tissue plasminogen activator (t-PA) levels.
  • Genetic analysis focused on identifying homozygous null mutations in the PLAT gene.

Main Results:

  • A homozygous null mutation in the PLAT gene was identified in affected siblings.
  • The identified mutation abrogated t-PA levels in patient cells, confirming a functional knockout.
  • This represents the first reported human knockout mutation of PLAT.

Conclusions:

  • The study reports the first human PLAT knockout mutation, leading to absent t-PA.
  • The findings suggest a potential association between PLAT deficiency and severe congenital anomalies, including hydranencephaly, diaphragmatic hernia, and postnatal lethality.
  • Further validation is required to confirm the causal link between PLAT mutations and these severe phenotypes.